EN DE
STOCK COMPARISON

Abbott Laboratories vs Japan Vietnam Medical Instrument JSC: Fair Value & Quality

Both stocks run through our valuation models. Here is how Abbott Laboratories (ABT) and Japan Vietnam Medical Instrument JSC (JVC) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees Japan Vietnam Medical Instrument JSC as the less overvalued of the two: Abbott Laboratories trades at $103 versus a fair value of $74.79 (-28%), while Japan Vietnam Medical Instrument JSC trades at VND 2,720 versus VND 2,362 (-13%).
Abbott Laboratories
ABT · USD · Health Care
-28%
upside to fair value
overvalued
Price$103
Fair Value$74.79
Quality66/100
Japan Vietnam Medical Instrument JSC
JVC.VN · VND · Health Care
-13%
upside to fair value
overvalued
PriceVND 2,720
Fair ValueVND 2,362
Quality50/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Abbott LaboratoriesJapan Vietnam Medical Instrument JSC
Valuation
28.5×P/E (TTM)n/a
4.01×P/S (TTM)n/a
3.47×P/Bn/a
15.5×EV/EBITDAn/a
1.47×PEGn/a
−27.7%Fair value upside−13.2%
2.4%Dividend yieldn/a
$2.44Dividend per sharen/a
Profitability
13%Operating margin12%
1.19×EBIT margin trend (5Y)n/a
12%Return on equity6%
6%Return on assets3%
Growth
8%Revenue growth (YoY)-12%
0.5%Avg. growth/yr (3Y)n/a
5.1%Avg. growth/yr (5Y)n/a
+10.6%Value creation/yrn/a
Balance & size
23.6×Interest coverage (EBIT/interest)n/a
0.19×Debt / equityn/a
$181BMarket cap$14M
healthyGrowth qualityweak

Abbott Laboratories leads: 3 to 1 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Abbott Laboratoriesof which business quality 66 · market factors 50 Japan Vietnam Medical Instrument JSCof which business quality 48 · market factors 22
ProfitabilityMargins and returns on capital today
50
11
Quality GrowthAre margins and returns improving?
47
63
CashflowEarnings quality: real cash, not paper profit
71
24
Fin. StrengthBalance sheet, leverage, solvency risk
80
67
InvestmentDisciplined investing over empire-building
65
67
Low VolatilityCalm price path (market factor)
83
66
MomentumPrice trend over the last 3–12 months (market factor)
43
7
52W MomentumDistance to the 52-week high (market factor)
25
0
Net IssuanceShare count: buybacks or dilution?
84
80

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyAbbott LaboratoriesPrice $103Japan Vietnam Medical Instrument JSCPrice VND 2,720
DCF Models-28%below the price$74.80+26%above the priceVND 3,429
Earnings-Based-72%below the price$29.42n/a
Dividend Discount-62%below the price$39.73n/a
Multiples-32%below the price$70.72+71%above the priceVND 4,639
Asset-Based-81%below the price$20.05-7%close to the priceVND 2,530
Growth DCF-34%below the price$68.58-2%close to the priceVND 2,667
Economic Profit-64%below the price$37.49n/a
Growth Earnings-32%below the price$70.25n/a
Minimum-81%below the price$20.05-7%close to the priceVND 2,530
Maximum-28%below the price$74.80+71%above the priceVND 4,639
Median-48%below the price$54.15+12%close to the priceVND 3,048
Geometric mean-55%below the price$46.64+18%above the priceVND 3,219

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Abbott Laboratories: 26 of 26 models see the stock below the current price.

Japan Vietnam Medical Instrument JSC: 5 of 11 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Abbott Laboratories
Price $103
Fair Value $74.79
Bear $52.12Bull $94.43
Japan Vietnam Medical Instrument JSC
Price VND 2,720
Fair Value VND 2,362
Bear VND 2,109Bull VND 2,844

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Abbott Laboratories · Health Care

Quality score66 · Top 25%
Fair value upside-28% · below median

Japan Vietnam Medical Instrument JSC · Health Care

Quality score50 · below median
Fair value upside-13% · above median

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees Japan Vietnam Medical Instrument JSC as the less overvalued of the two: Abbott Laboratories trades at $103 versus a fair value of $74.79 (-28%), while Japan Vietnam Medical Instrument JSC trades at VND 2,720 versus VND 2,362 (-13%).

Abbott Laboratories has the higher quality score (66/100).

Open Japan Vietnam Medical Instrument JSC live analysis →
Abbott Laboratories · Japan Vietnam Medical Instrument JSC

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Abbott Laboratories

Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor Manufacturing

Related to Japan Vietnam Medical Instrument JSC

Alphabet Inc Class C vs Meta PlatformsCisco Systems vs NvidiaMicrosoft vs Taiwan Semiconductor ManufacturingApple vs Cisco Systems
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.